Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/09/2005EP0917569B1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
11/09/2005EP0904380B1 Synthetic hiv genes
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
11/09/2005EP0772455B1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
11/09/2005EP0769024B1 High-affinity melatonin receptors and uses thereof
11/09/2005EP0716615B1 Low flux transdermal potent drug delivery system
11/09/2005CN1695059A Method of diagnosing colon and gastric cancers
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694889A Phenyl-aza-benzimidazole compounds for modulating ige and inhibiting cellular proliferation
11/09/2005CN1694885A Process for the preparation of imipenem
11/09/2005CN1694882A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
11/09/2005CN1694881A New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694871A Imidazolopyridines and methods of making and using the same
11/09/2005CN1694868A Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
11/09/2005CN1694867A Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1694736A Medical devices containing rapamycin analogs
11/09/2005CN1694717A Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation
11/09/2005CN1694714A Formulation for inwardly transferring nucleic acids into eucaryotic cells
11/09/2005CN1694713A Stable oxazaphosphorine-2-mercaptoethanesulphonate formulations
11/09/2005CN1694712A Inhalation composition
11/09/2005CN1694711A A method of extending the dose range of vitamin d compounds
11/09/2005CN1694710A Pharmaceutical application of 15- or 16- substituted testosterone analogues
11/09/2005CN1694709A Antibacterial medicinal composition of enhanced oral absorptivity
11/09/2005CN1694707A Pde-v inhibitor and medicine composite with active agent
11/09/2005CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
11/09/2005CN1694703A Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
11/09/2005CN1694702A Neurotrophic factor production promoter
11/09/2005CN1694701A Methods for treating disorders associated with mGLU receptors including addiction and depression
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
11/09/2005CN1694699A Percutaneous absorption preparations containing 3-methyl-phenyl-2-pyrazolin-5-one
11/09/2005CN1694698A Pyrazolopyridines and methods of making and using the same
11/09/2005CN1694697A Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for
11/09/2005CN1694696A Use of iminosugar derivatives to inhibit ion channel activity
11/09/2005CN1694695A Novel nutraceutical compositions comprising epigallocatechin gallate
11/09/2005CN1694694A Eicosapentaenoic acid (EPA) for treating anorexia nervosa (AN) and bulimia
11/09/2005CN1694693A Blood fluidity improving agent
11/09/2005CN1694692A Hypogastric and/or perineal pain-relieving agent
11/09/2005CN1694691A Treatment of metastatic breast cancer with anthracyclines and taxanes
11/09/2005CN1694690A Combination chemotherapy compositions and methods
11/09/2005CN1694689A Sustained release pharmaceutical formulation for inhalation
11/09/2005CN1694688A Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
11/09/2005CN1694686A Modified release oral dosage form
11/09/2005CN1694490A Method, equipment and computer program of changed digital color image
11/09/2005CN1692911A Application of cilostazol for preparing medicine to treat bradycardia
11/09/2005CN1692910A Oral prepn. of disodium adenosine triphosphate
11/09/2005CN1692909A Dosmalfate dispersion tablet and its prepn. method
11/09/2005CN1692908A Application of timosaponin B II for preparing medicine or products for treating and preventing stroke
11/09/2005CN1692907A Composite for treating hyperlipidemia
11/09/2005CN1692906A Composite for treating hyperlipidemia
11/09/2005CN1692905A Composite for treating hyperlipidemia
11/09/2005CN1692904A Epalorestat capsule, and its prepn. method
11/09/2005CN1692903A Epalrestat tablet, and its prepn. method
11/09/2005CN1692902A Colchicine osmosis pump tablet, and its prepn. method
11/09/2005CN1692901A Application of magnolol for preparing medicine compositions to treat and prevent tumor
11/09/2005CN1226304C Methylene steroids as novel androgens
11/09/2005CN1226302C Ibuprofen triaazole nucleoside ester and preparation method and use thereof
11/09/2005CN1226300C Ibuprofen sugar conjugated product and its preparation method and application
11/09/2005CN1226297C Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same
11/09/2005CN1226294C Fused heteroaromatic glucokinase activators
11/09/2005CN1226292C Diazesuberane derivant or its salt
11/09/2005CN1226290C Ligands of nuclear receptor
11/09/2005CN1226047C Pharmaceutical compositions
11/09/2005CN1226037C Use of sucralfate for the treatment of cervical erosion
11/09/2005CN1226036C New therapeutic combinations of mirtazapine and antipsychotic agents, for treatment of prophylaxis of psychotic disorders
11/09/2005CN1226035C New use of iloperidone
11/09/2005CN1226034C Durably antibacterial and deodouring medicine for treating tinea manuum and tinea pedis
11/08/2005WO2005073234A2 Imidazo[1,2-c]pyrimidinylacetic acid derivatives
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6963000 Benzothiazole derivatives with activity as adenosine receptor ligands
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962945 N-aryloxypropanolyl-N′-phenethyl-urea
11/08/2005US6962944 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962940 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
11/08/2005US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962934 Such as N-((2S)-2-((3-((dipropylamino)carbonyl)-benzoyl) amino)-3-phenylpropyl)-L-alanyl-N1-isobutyl-L-valinamide; secretase inhibitors
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962931 Oral bioavailability of a CETP inhibitor
11/08/2005US6962930 such as N,N-diphenyl)-4-ureido-5,7-dichloro-2-carboxyquinolinefor treatment of drug abuse/dependence; side effects reduction
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/08/2005US6962928 such as 6-methoxy-2-(4-methoxyphenyl)-1-[4-(2-piperidin-1-yl-ethyoxy)-phenyl]-1,2,3,4-tetrahydroquinoline
11/08/2005US6962927 using d-tetrandrine and its derivatives to reverse or inhibit the glycoprotein pump of a multidrug resistant cell so that they accept a greater concentration of drug than drug resistant cells; for treating cancer, AIDS pneumonia etc
11/08/2005US6962926 monocyte chemoattractant protein-1 (MCP-1); 1-{1,3-dimethyl-6-[2-(pyrrolidin-1-yl)ethoxy]-1H-pyrazolo[3,4-b]pyridine-5-carbonyl}-3-(3-isopropoxyphenyl)urea; inflammatory/autoimmune diseases (multiple sclerosis), and allergic hypersensitivity
11/08/2005US6962925 useful for the treatment of the pathologies mediated by the enzyme or for agricultural uses as plant growth regulators or herbicides
11/08/2005US6962924 Antihistamines; side effect reduction
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962921 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
11/08/2005US6962919 Gonadotropin-releasing hormone antagonizing activity; useful as prophylactic or therapeutic agent for sex hormone-dependent diseases
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962917 E.g., (R)-2-(4-((4-fluoro-1H-benzimidazol-2-ylmethyl)-amino)-piperidin-1-yl)-1-(6- methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
11/08/2005US6962916 For therapy of retrovirus infection
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962914 Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds